Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group?

被引:0
|
作者
Choi, S. [1 ]
Levy, L. B. [1 ]
Lee, K. K. [1 ]
Nguyen, Q. N.
Lee, A. K. [2 ,3 ]
McGuire, S. E. [1 ]
Kudchadker, R. [1 ]
Du, W. [1 ]
Hoffman, K. E. [1 ]
Mahmood, U. [1 ]
Frank, S. J. [1 ]
Kuban, D. A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Texas Ctr Proton Therapy, Irving, TX USA
关键词
D O I
10.1016/j.ijrobp.2016.06.1228
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2586
引用
收藏
页码:E240 / E241
页数:2
相关论文
共 50 条
  • [1] IMPACT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON THE CLINICAL OUTCOMES OF HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER
    Lee, Hyung Ho
    Lim, Meng Shi
    Yu, Ho Song
    Bang, Woo Jin
    Rha, Koon Ho
    Hong, Sung Jun
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E314 - E314
  • [2] Clinical Outcomes of Very High-risk Prostate Cancer Treated with Proton Therapy
    Sosa, Alan
    Choi, Seungtaek
    Nguyen, Quynh-Nhu
    Kudchadker, Reena
    Sanders, Jeremiah
    Zhu, Ronald
    Shah, Shalin
    Mok, Henry
    Kuban, Deborah
    Mayo, Lauren
    Hoffman, Karen
    Tang, Chad
    McGuire, Sean
    Ausat, Noveen
    Thames, Howard
    Frank, Steven
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S5 - S5
  • [3] Feeding the Controversy: When Pelvic Irradiation Improves Outcomes in High-Risk and Very High-Risk Prostate Cancer
    Jan, Imraan
    Parikh, Rahul R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (11) : 1196 - +
  • [4] Obstructive sleep apnoea outcomes after surgery: identifying high-risk patients from a high-risk group
    Liddicoat, P.
    Duffen, A.
    Howes, H.
    Hood, E.
    Wilson, H.
    [J]. ANAESTHESIA, 2023, 78 : 31 - 31
  • [5] Oncological and functional outcomes of high-risk and very high-risk prostate cancer patients after robot-assisted radical prostatectomy
    Chen, Wei-Hsin
    Lee, Yu Khun
    Kuo, Hann-Chorng
    Wang, Jen-Hung
    Jiang, Yuan-Hong
    [J]. PLOS ONE, 2023, 18 (03):
  • [6] Neoadjuvant and adjuvant chemohormonal therapy in patients with high-risk and very high-risk prostate cancer: our experience
    Ustinova, T., V
    Nyushko, K. M.
    Bolotina, L., V
    Kharchenko, N., V
    Paychadze, A. A.
    Taraki, I. A.
    Alekseev, B. Ya
    Krasheninnikov, A. A.
    Kaprin, A. D.
    [J]. ONKOUROLOGIYA, 2018, 14 (03): : 58 - 67
  • [7] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Saad, Akram
    Goldstein, Jeffrey
    Lawrence, Yaacov R.
    Spieler, Benjamin
    Leibowitz-Amit, Raya
    Berger, Raanan
    Davidson, Tima
    Urban, Damien
    Tsang, Lev
    Alezra, Dror
    Weiss, Ilana
    Symon, Zvi
    [J]. RADIATION ONCOLOGY, 2017, 12
  • [8] Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
    Akram Saad
    Jeffrey Goldstein
    Yaacov R. Lawrence
    Benjamin Spieler
    Raya Leibowitz-Amit
    Raanan Berger
    Tima Davidson
    Damien Urban
    Lev Tsang
    Dror Alezra
    Ilana Weiss
    Zvi Symon
    [J]. Radiation Oncology, 12
  • [9] clinical outcomes of radiation therapy for high-risk prostate cancer
    Gumenetskaya, Y.
    Makarova, K.
    Biryukov, V.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S208 - S208
  • [10] Use of biopsy detail to identify subgroup risk in high-risk patients with prostate cancer
    Townsend, Natasha C.
    Buyyounouski, Mark K.
    Ruth, Karen J.
    Kutikov, Alexander
    Viterbo, Rosalia
    Sobczak, Mark
    White, Terry
    Horwitz, Eric M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)